Post-marketing Observational Clinical Study: Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice
Men and women aged 18 to 65 years;
BMI 18.5 - 40;
Verified diagnosis: chronic acalculous cholecystitis;
Voluntary desire to provide informed consent to participate in the study
Presence of stones in the gall bladder and bile ducts;
The presence of jaundice, cholestatic liver diseases, liver cirrhosis with decompensation;
Increased ALT, AST above the 3 upper limits of normal;
Hypersensitivity to the components of the drug Odeston;
Kazakhstan Scientific Society for Study of intestine diseases
Lead sponsor